XML 54 R43.htm IDEA: XBRL DOCUMENT v3.25.3
Collaborative Arrangements - Ridgeback Biotherapeutics LP (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sales $ 17,276 $ 16,657 $ 48,611 $ 48,544  
Cost of sales 3,855 4,080 10,831 11,365  
Selling, general and administrative 2,633 2,731 7,835 7,952  
Accrued and other current liabilities 16,186   16,186   $ 15,694
Ridgeback Biotherapeutics LP | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Cost of sales 81 204 178 491  
Selling, general and administrative 11 11 39 43  
Research and development 11 5 25 7  
Accrued and other current liabilities 49   49   $ 68
Ridgeback Biotherapeutics LP | Lagevrio | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement          
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]          
Sales $ 138 $ 383 $ 323 $ 843